← SynDRA
BURIXAFOR
SynDRA canonical compound SYN0038247 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CXCR4 |
|---|
| Mechanism of action | cc chemokine receptor antagonist |
|---|
| Indication | multiple myeloma |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
- CXCR4 ANTAGONIST
- C-X-C chemokine receptor type 4 antagonist
- cc chemokine receptor antagonist
- CXCR4 INHIBITOR
Cross-references
Synonyms
- Tg-0054
- TG-0054
- CXCR4 binding inhibitor/cell mobilizer (iv, stem cell transplant), TaiGen Biotechnology
- Burixafor [INN]
- TG 0054
- 2G17Y0Q20G
- UNII-2G17Y0Q20G
- TG0054
- BURIXAFOR [WHO-DD]
- orb2815410
- SCHEMBL13332861
- SCHEMBL14693228
- SCHEMBL14693238
- SB17205
- NS00073707
- T202297
- Burixafor hydrobromide hydrate
- E5X126RWIU
- RXB45019
- DA-71819
- Burixafor hydrobromide (TG-0054 hydrobromide)
- Burixafor HBr
- orb1710191
- T10635
- Burixafor hydrobromide
- G16612
Look up BURIXAFOR in the interactive SynDRA portal →